Lista de obras -

A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.

artículo científico publicado en 2015

Abstract 109: CSE1L , a 20q gain passenger that drives colorectal adenoma to carcinoma progression

artículo científico publicado en 2012

Abstract 3042: TPX2 and AURKA promote 20q amplicon driven colorectal adenoma-to-carcinoma progression

artículo científico publicado en 2011

Abstract 4526: Lumican and Versican predict good outcome in stage II and III colon cancer

artículo científico publicado en 2012

BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain

scientific article published on 18 October 2011

CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients

CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.

artículo científico publicado en 2012

Cell cycle proteins predict recurrence in stage II and III colon cancer.

artículo científico publicado en 2012

Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.

artículo científico publicado en 2011

Consensus molecular subtype classification of colorectal adenomas

artículo científico publicado en 2018

Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence ⬇️

artículo científico publicado el 19 de noviembre de 2013

Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis

artículo científico publicado en 2020

Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis

artículo científico publicado en 2016

Identification of differentially expressed splice variants by the proteogenomic pipeline Splicify

artículo científico publicado en 2017

Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression

artículo científico publicado en 2010

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.

artículo científico publicado en 2016

Lumican and versican are associated with good outcome in stage II and III colon cancer.

artículo científico publicado en 2012

Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression

artículo científico publicado en 2017

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer

artículo científico publicado en 2018

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.

artículo científico publicado en 2015

Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression

artículo científico publicado en 2019

Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237).

artículo científico publicado en 2015

Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum

artículo científico publicado en 2008

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study

scientific article published on 16 August 2019

Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.

artículo científico publicado en 2012

Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer

artículo científico publicado en 2020

TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.

artículo científico publicado en 2011

Lista de obras de

A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.

Abstract 109: CSE1L , a 20q gain passenger that drives colorectal adenoma to carcinoma progression

Abstract 3042: TPX2 and AURKA promote 20q amplicon driven colorectal adenoma-to-carcinoma progression

Abstract 4526: Lumican and Versican predict good outcome in stage II and III colon cancer

BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain

CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients

CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.

Cell cycle proteins predict recurrence in stage II and III colon cancer.

Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.

Consensus molecular subtype classification of colorectal adenomas

Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence ⬇️

Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis

Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis

Identification of differentially expressed splice variants by the proteogenomic pipeline Splicify

Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.

Lumican and versican are associated with good outcome in stage II and III colon cancer.

Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.

Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression

Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237).

Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study

Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.

Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer

TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.